| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $130.0M | +201.9% |
| R&D Expense | $305.7M | +123.4% |
| SG&A Expense | $245.1M | +244.9% |
| Operating Income | -$633.7M | -172.6% |
| Pre-tax Income | -$556.7M | -67.9% |
| Income Tax | -$44.6M | — |
| Net Income | -$510.4M | -53.9% |
| EPS (Basic) | -$1.82 | -16.7% |
| EPS (Diluted) | -$1.82 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +1795.2% |
| Short-term Investments | $1.36B | +376.1% |
| Accounts Receivable | $66.5M | +553.0% |
| Inventory | $10.3M | — |
| Current Assets | $2.59B | +582.8% |
| Total Assets | $6.57B | +1192.4% |
| Current Liabilities | $166.8M | +362.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$283.2M | -168.0% |
| Capital Expenditures | $16.4M | -8.8% |
| Investing Cash Flow | -$2.10B | -2632.4% |
| Financing Cash Flow | $3.36B | +7956.7% |
| Free Cash Flow | -$299.6M | -142.3% |
| -16.7% |
| Total Liabilities |
| $2.76B |
| +2113.7% |
| Stockholders' Equity | $3.80B | +889.8% |